Frontlight ResearchEarly access
Trial site
Hospital Córdoba
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Epilepsy3 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Myasthenia gravis1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Xenon Pharmaceuticals Inc.3 trials
- Boehringer Ingelheim1 trial
- Janssen Pharmaceutica N.V., Belgium1 trial
- Lakefront Biotherapeutics NV1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy1 recruiting
- Myasthenia gravis1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026